Research Article
Gastrointestinal Bleeding due to Pancreatic Disease-Related Portal Hypertension
Table 1
Characteristics of the patients with left-sided portal hypertension.
| | Variables | 1 (TL) | 2 (YC) | 3 (WZ) | 4 (JH) | 5 (HW) |
| | Gender | Male | Male | Male | Male | Male | | Age (years) | 68 | 33 | 67 | 36 | 64 | | Pancreatic diseases | Pancreatic cancer | Pancreatitis | Pancreatic cancer | Pancreatitis | Pancreatic cancer | | Locations of the pancreatic diseases | Head, body, and tail | Head | Tail | Body and tail | Body and tail | | Clinical presentation | Melena | Hematemesis and melena | Blood in stomach | Hematemesis and melena | Hematemesis | | Gastrointestinal bleeding at admission | Yes | Yes | Yes | Yes | Yes | | Comorbidities | Left renal clear cell cancer
Left upper lung lobe metastatic cancer
Thyroid metastatic cancer
Left upper limb bone metastatic cancer | Recurrent pancreatitis
Diabetes | Hypertension | Recurrent pancreatitis
Coronary heart disease
Hypertension | Lacunar infarction | | EGD | Gastric varices | Esophagogastric varices | Gastric varices | Gastric varices | Gastric varices | | Laboratory tests at admission | | WBC (109/L) | 3.4 | 4.9 | 5.1 | 8.6 | 4.9 | | GR (%) | 63.4 | 75.8 | 66.8 | 66.5 | 79.2 | | RBC (1012/L) | 2.63 | 4.27 | 3.05 | 4.00 | 4.01 | | HB (g/L) | 74 | 111 | 76 | 108 | 125 | | PLT (109/L) | 78 | 71 | 209 | 205 | 78 | | TBIL (μmol/L) | 15.4 | 15.1 | 7.7 | 27.1 | 17.4 | | DBIL (μmol/L) | 9.2 | 3.7 | 2.2 | 7.8 | 4.4 | | ALT (U/L) | 116.02 | 14.55 | 12.59 | 8.09 | 23.33 | | AST (U/L) | 109.59 | 15.4 | 17.14 | 9.75 | 30.92 | | AKP (U/L) | 361.51 | 60.66 | 88.37 | 81.02 | 96.56 | | GGT (U/L) | 199.51 | 23.41 | 18.4 | 32.31 | 124 | | AMY (U/L) | 79.00 | 52.00 | NA | 92.00 | 145.00 | | LIPA (U/L) | 457.0 | 45.0 | NA | 394.0 | 52.0 | | Types of treatment | Endoscopic variceal treatment
Pharmacological treatment | Pharmacological treatment | Distal pancreatectomy and splenectomy
Pharmacological treatment | Pharmacological treatment | Endoscopic spraying fluid film
Chemotherapy
Pharmacological treatment | | Outcomes | Died | Died | Survived | Survived | Survived |
|
|
Abbreviations: EGD: esophagogastroduodenoscopy; WBC: white blood cell; GR%: neutrophil percentage; RBC: red blood cell; HB: hemoglobin concentration; PLT: platelet; TBIL: total bilirubin; DBIL: direct bilirubin; ALT: alanine aminotransaminase; AST: aspartate aminotransferase; AKP: alkaline phosphatase; GGT: γ-glutamyl transpeptidase: NA: not available; AMY: amylase; LIPA: lipase. The reference range of laboratory tests: WBC: ; GR%: 40-75%; RBC: ; HB: ; PLT: ; TBIL: 5.1-20.0 μmol/L; DBIL: 0-6.8 μmol/L; ALT: 7-50 U/L; AST: 13-40 U/L; AKP: 13-150 U/L; GGT: 7-60 U/L; AMY: 30-110 U/L; LIPA: 23-300 U/L. |
